Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

MLA

Sandy Nassif, et al. “Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.” In Vivo, vol. 36, Jan. 2022, pp. 821–32. EBSCOhost, https://doi.org/10.21873/invivo.12769.

APA

Sandy Nassif, Jorn Wichmann, Dominic Strube, Stratos Vassis, Hans Christiansen, & Diana Steinmann. (2022). Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma. In Vivo, 36, 821–832. https://doi.org/10.21873/invivo.12769

Chicago

Sandy Nassif, Jorn Wichmann, Dominic Strube, Stratos Vassis, Hans Christiansen, and Diana Steinmann. 2022. “Cisplatin Versus Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.” In Vivo 36 (January): 821–32. doi:10.21873/invivo.12769.